SCHEMBL16219009

SCHEMBL16219009

CC(C)C(=O)N(C)CC1CCCCO1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MLYCD O95822 1/20 0.42
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 1/20 0.41
HSD17B10 Q99714 1/20 0.41
KMT2A Q03164 4/20 0.39
MEN1 O00255 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 4/20 0.38
RAB9A P51151 3/20 0.38
POLB P06746 2/20 0.38
NAMPT P43490 1/20 0.37
LMNA P02545 2/20 0.37
DPP4 P27487 1/20 0.37
PREP P48147 1/20 0.37
FAP Q12884 1/20 0.37
PER2 O15055 1/20 0.36
CRY1 Q16526 1/20 0.36
CRY2 Q49AN0 1/20 0.36
HPGD P15428 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17152350 0.83 ALDH1A1 (0.35) MLYCDALDH1A1KDM4EHSD17B10KMT2A
SCHEMBL14970372 0.81 NAMPT (0.42) ALDH1A1KDM4EHSD17B10KMT2AMEN1
SCHEMBL19652176 0.81 CHRM4 (0.37) MLYCDALDH1A1KDM4EHSD17B10KMT2A
SCHEMBL17152408 0.78 ANPEP (0.38) MLYCDALDH1A1KDM4EHSD17B10KMT2A
SCHEMBL16750116 0.77 CHRM2 (0.39) MLYCDALDH1A1KDM4EHSD17B10KMT2A
SCHEMBL14276878 0.76 NAMPT (0.45) ALDH1A1KDM4EHSD17B10KMT2ASMN1; SMN2
SCHEMBL10104198 0.74 ALDH1A1 (0.37) ALDH1A1KMT2AMEN1SMN1; SMN2LMNA
SCHEMBL16219074 0.74 ALOX5 (0.44) SMN1; SMN2DPP4PREPFAP
SCHEMBL17516260 0.74 ALDH1A1 (0.48) MLYCDALDH1A1KDM4EHSD17B10RAB9A
SCHEMBL17152348 0.74 PSEN1 (0.35) ALDH1A1KDM4EHSD17B10KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9018224-B2 Substituted cyclopropyl compounds useful as GPR119 agonists MERCK SHARP & DOHME CORP. (US) 2015-04-28 US disclosed
US-20140329798-A1 SUBSTITUTED CYCLOPROPYL COMPOUNDS USEFUL AS GPR119 AGONISTS MERCK SHARP & DOHME LLC 2014-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140329798-A1 SUBSTITUTED CYCLOPROPYL COMPOUNDS USEFUL AS GPR119 AGONISTS GPR119, GPR27, GCGR MLYCD 1389/4885ALDH1A1 1827/4885KDM4E 3904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.